VEGENICS LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
C07K PEPTIDES 8128
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C08F MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1124
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
H02P CONTROL OR REGULATION OF ELECTRIC MOTORS, GENERATORS, OR DYNAMO-ELECTRIC CONVERTERS; CONTROLLING TRANSFORMERS, REACTORS OR CHOKE COILS 186

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7947472 Expression vectors and cell lines expressing vascular endothelial growth factor DDec 23, 98May 24, 11[C07H, C12N]
7863851 Closed loop stepper motor controlAug 22, 07Jan 04, 11[H02P]
7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using sameJun 30, 08Dec 07, 10[A61K, C12P]
7794756 Methods of using antibodies to VEGF-COct 30, 07Sep 14, 10[A61K, C12N]
7727761 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofMar 03, 04Jun 01, 10[A01N, C12N, A01K]
7709270 Vascular endothelial growth factor C (VEGF-C) protein diagnosticOct 30, 07May 04, 10[C07K]
7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissueJul 28, 03May 19, 09[C12P, G01N]
7307107 Photopolymerizable composition and use thereofJul 17, 03Dec 11, 07[C08F]
7097986 Antibodies to truncated VEGF-D and uses thereofFeb 18, 04Aug 29, 06[G01N]
7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitorJan 18, 01May 16, 06[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2012/0125,348 AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERYAbandonedOct 21, 11May 24, 12[A61B]
2011/0269,146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating MelanomasAbandonedNov 05, 10Nov 03, 11[G01N]
2011/0243,912 Growth Factor Binding Constructs Materials and MethodsAbandonedDec 17, 10Oct 06, 11[A61K, C07H, C12N, A61P]
2011/0189,170 Chimeric Anti-VEGF-D Antibodies and Humanized Anti-VEGF-D Antibodies and Methods of Using the SameAbandonedDec 03, 10Aug 04, 11[A61K, C07H, A61P, C07K]
2011/0142,839 TREATMENT OF PULMONARY EDEMAAbandonedMay 29, 09Jun 16, 11[A61K, A61P]
7887800 Methods for inhibiting VEGF-DExpiredDec 09, 08Feb 15, 11[A61K, C07K]
7855178 Growth factor binding constructs materials and methodsExpiredJul 28, 08Dec 21, 10[A61K, C12P]
7829536 Method of treating lymphedema comprising administering VEGF-DExpiredFeb 05, 09Nov 09, 10[A61K]
2010/0041,605 Use of VEGF-C or VEGF-D in Reconstructive SurgeryAbandonedJun 23, 09Feb 18, 10[A61K, A61P]
7611711 VEGFR-3 inhibitor materials and methodsExpiredJan 15, 02Nov 03, 09[A61K, C07K]
7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsExpiredAug 28, 07Jul 28, 09[C12N]
7479270 Methods and compositions for activating VEGF-D and VEGF-CExpiredJul 21, 03Jan 20, 09[A61K, C07K]
2009/0017,011 MODULATION OF VEGF-C/VEGFR-3 INTERACTIONS IN THE TREATMENT OF RHEUMATOID ARTHRITISAbandonedJun 13, 08Jan 15, 09[A61K, A61P]
2008/0267,924 AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERYAbandonedFeb 07, 08Oct 30, 08[A61K]
7422741 VEGFR-3 fusion proteinsExpiredMar 07, 05Sep 09, 08[C07K]
7423125 Antibodies to VEGF-CExpiredMar 03, 04Sep 09, 08[C07K]
7420042 Soluble neuropilin/growth factor receptor fusion proteinsExpiredNov 26, 02Sep 02, 08[C12P]
2008/0145,366 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useAbandonedMar 28, 07Jun 19, 08[A61K, C07H, C12N, C07K]
2008/0147,045 Use of VEGF-C or VEGF-D in Reconstructive SurgeryAbandonedJul 24, 07Jun 19, 08[A61K, A61F, A61P, A61M]
7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsExpiredFeb 24, 05Dec 18, 07[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.